Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck
โ Scribed by Jay S. Cooper; Qiang Zhang; Thomas F. Pajak; Arlene A. Forastiere; John Jacobs; Scott B. Saxman; Julie A. Kish; Harold E. Kim; Anthony J. Cmelak; Marvin Rotman; Robert Lustig; John F. Ensley; Wade Thorstad; Christopher J. Schultz; Sue S. Yom; K. Kian Ang
- Book ID
- 118457393
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 342 KB
- Volume
- 84
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: For patients treated with combination resection and postoperative radiotherapy, the interval between surgery and completion of radiotherapy represents an opportunity for tumor repopulation and treatment failure. a prospective trial to test the feasibility and efficacy of accelerated
The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.
## Abstract ## BACKGROUND The authors conducted a Phase I/II study in patients with a poor prognosis who had locally advanced squamous cell carcinoma of the head and neck (SCCHN) and who were treated initially with induction chemotherapy. Patients were treated with weekly docetaxel and concurrent